CMMB Chemomab Therapeutics Ltd.
Healthcare · Market cap: $880.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $52.2K | $0 |
| 2022-Q2 | $7.6K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $1.2M |
| 2023-Q1 | $0 | $1.3M |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $6.5K |
| 2026-Q4 | $0 | $0 |
Bought$74.7K9 buy days
Sold$2.5M6 sell days
Net insider flow-$2.4Mnet selling · 5 years
Latest trade2026-08-28Cohen Neil Harris
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-28 | Sell | Cohen Neil Harris | Director | 1,000 | $2.80 | $2.8K | 1 |
| 2026-08-27 | Sell | Cohen Neil Harris | Director | 1,304 | $2.85 | $3.7K | 1 |
| 2023-01-03 | Sell | OrbiMed Israel GP Ltd. | 10% owner | 336,900 | $3.58 | $1.2M | 2 |
| 2023-01-03 | Sell | Mor George Adi | Other C-suite | 13,800 | $5.03 | $69.4K | 2 |
| 2022-11-16 | Sell | Mor George Adi | Other C-suite | 582,023 | $2.08 | $1.2M | 2 |
| 2022-11-16 | Sell | Cohen Neil Harris | Director | 2,409 | $2.00 | $4.8K | 1 |
| 2022-05-24 | Buy | Maryles Joel Michael | Director | 433 | $2.88 | $1.2K | 2 |
| 2022-05-18 | Buy | Cohen Neil Harris | Director | 2,000 | $3.19 | $6.4K | 1 |
| 2022-03-18 | Buy | Maryles Joel Michael | Director | 1,000 | $4.34 | $4.3K | 2 |
| 2022-03-16 | Buy | Marvin Donald | CFO | 500 | $3.27 | $1.6K | 2 |
| 2022-03-14 | Buy | Cohen Neil Harris | Director | 6,000 | $4.35 | $26.1K | 3 |
| 2022-03-14 | Buy | Pfost Dale R | CEO | 2,500 | $3.98 | $9.9K | 2 |
| 2022-03-14 | Buy | Marvin Donald | CFO | 1,250 | $4.04 | $5.0K | 5 |
| 2022-03-11 | Buy | Darvish Nissim | Director | 1,200 | $4.28 | $5.1K | 1 |
| 2021-12-06 | Buy | Cohen Neil Harris | Director | 2,000 | $7.43 | $14.9K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Mor George Adi | Other C-suite | $0 | $1.3M | 2023-01-03 |
| OrbiMed Israel GP Ltd. | 10% owner | $0 | $1.2M | 2023-01-03 |
| Cohen Neil Harris | Director | $47.4K | $11.3K | 2026-08-28 |
| Pfost Dale R | CEO | $9.9K | $0 | 2022-03-14 |
| Marvin Donald | CFO | $6.7K | $0 | 2022-03-16 |
| Maryles Joel Michael | Director | $5.6K | $0 | 2022-05-24 |
| Darvish Nissim | Director | $5.1K | $0 | 2022-03-11 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-03-11 → 2022-03-18 | 5 | $52.2K | 51 | -9.1% (-8.2% raw) | -3.8% (-16.4% raw) | -13.6% (-21.2% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.